 | • レポートコード：D0804-09867 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、106ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ペットワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。ペットワクチンの種類別市場規模（弱毒生ワクチン、複合ワクチン、不活化ワクチン、サブユニットワクチン、トキソイドワクチン、DNAワクチン、組換えワクチン）、用途別市場規模（犬、鳥、猫）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Bayer Healthcare、Merial (Sanofi)、Ceva、Vetoquinol S.A、Merck Animal Health、Boehringer Ingelheim、Zoetis (Pfizer)、Heska Co.、Eli Lilly、Virbac ・地域別グローバル市場分析 2015年-2020年 ・ペットワクチンの北米市場（アメリカ、カナダ、メキシコ） ・ペットワクチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ペットワクチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ペットワクチンの南米市場（ブラジル、アルゼンチン） ・ペットワクチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：弱毒生ワクチン、複合ワクチン、不活化ワクチン、サブユニットワクチン、トキソイドワクチン、DNAワクチン、組換えワクチン ・用途別分析：犬、鳥、猫 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Pet Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Pet Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Pet Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Pet Vaccine market has been segmented into
Attenuated Live Vaccines
Conjugate Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
DNA Vaccines
Recombinant Vaccines
By Application, Pet Vaccine has been segmented into:
Canine
Avian
Feline
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Pet Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Pet Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Pet Vaccine market.
The report offers in-depth assessment of the growth and other aspects of the Pet Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Pet Vaccine Market Share Analysis
Pet Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Pet Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Pet Vaccine sales, revenue and market share for each player covered in this report.
The major players covered in Pet Vaccine are:
Bayer Healthcare
Merial (Sanofi)
Ceva
Vetoquinol S.A
Merck Animal Health
Boehringer Ingelheim
Zoetis (Pfizer)
Heska Co.
Eli Lilly
Virbac
Among other players domestic and global, Pet Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pet Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pet Vaccine, with price, sales, revenue and global market share of Pet Vaccine in 2018 and 2019.
Chapter 3, the Pet Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pet Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Pet Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Pet Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Pet Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pet Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Attenuated Live Vaccines
1.2.3 Conjugate Vaccines
1.2.4 Inactivated Vaccines
1.2.5 Subunit Vaccines
1.2.6 Toxoid Vaccines
1.2.7 DNA Vaccines
1.2.8 Recombinant Vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global Pet Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Canine
1.3.3 Avian
1.3.4 Feline
1.4 Overview of Global Pet Vaccine Market
1.4.1 Global Pet Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bayer Healthcare
2.1.1 Bayer Healthcare Details
2.1.2 Bayer Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Bayer Healthcare SWOT Analysis
2.1.4 Bayer Healthcare Product and Services
2.1.5 Bayer Healthcare Pet Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Merial (Sanofi)
2.2.1 Merial (Sanofi) Details
2.2.2 Merial (Sanofi) Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Merial (Sanofi) SWOT Analysis
2.2.4 Merial (Sanofi) Product and Services
2.2.5 Merial (Sanofi) Pet Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Ceva
2.3.1 Ceva Details
2.3.2 Ceva Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Ceva SWOT Analysis
2.3.4 Ceva Product and Services
2.3.5 Ceva Pet Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Vetoquinol S.A
2.4.1 Vetoquinol S.A Details
2.4.2 Vetoquinol S.A Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Vetoquinol S.A SWOT Analysis
2.4.4 Vetoquinol S.A Product and Services
2.4.5 Vetoquinol S.A Pet Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Merck Animal Health
2.5.1 Merck Animal Health Details
2.5.2 Merck Animal Health Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Merck Animal Health SWOT Analysis
2.5.4 Merck Animal Health Product and Services
2.5.5 Merck Animal Health Pet Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Boehringer Ingelheim
2.6.1 Boehringer Ingelheim Details
2.6.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Boehringer Ingelheim SWOT Analysis
2.6.4 Boehringer Ingelheim Product and Services
2.6.5 Boehringer Ingelheim Pet Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Zoetis (Pfizer)
2.7.1 Zoetis (Pfizer) Details
2.7.2 Zoetis (Pfizer) Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Zoetis (Pfizer) SWOT Analysis
2.7.4 Zoetis (Pfizer) Product and Services
2.7.5 Zoetis (Pfizer) Pet Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Heska Co.
2.8.1 Heska Co. Details
2.8.2 Heska Co. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Heska Co. SWOT Analysis
2.8.4 Heska Co. Product and Services
2.8.5 Heska Co. Pet Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Eli Lilly
2.9.1 Eli Lilly Details
2.9.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Eli Lilly SWOT Analysis
2.9.4 Eli Lilly Product and Services
2.9.5 Eli Lilly Pet Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Virbac
2.10.1 Virbac Details
2.10.2 Virbac Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Virbac SWOT Analysis
2.10.4 Virbac Product and Services
2.10.5 Virbac Pet Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Pet Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Pet Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Pet Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Pet Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Pet Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Pet Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Pet Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Pet Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Pet Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Pet Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Pet Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Pet Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Pet Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Pet Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Pet Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Pet Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Pet Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Pet Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Pet Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Pet Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Pet Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Pet Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Pet Vaccine Sales and Growth Rate (2015-2020)
6.4 France Pet Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Pet Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Pet Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Pet Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Pet Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Pet Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Pet Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Pet Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Pet Vaccine Sales and Growth Rate (2015-2020)
7.5 India Pet Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Pet Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Pet Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Pet Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Pet Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Pet Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Pet Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Pet Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Pet Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Pet Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Pet Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Pet Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Pet Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Pet Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Pet Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Pet Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Pet Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Pet Vaccine Price by Type (2015-2020)
11 Global Pet Vaccine Market Segment by Application
11.1 Global Pet Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Pet Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Pet Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Pet Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Pet Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Pet Vaccine Market Forecast (2021-2025)
12.2.2 Europe Pet Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Pet Vaccine Market Forecast (2021-2025)
12.2.4 South America Pet Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Pet Vaccine Market Forecast (2021-2025)
12.3 Pet Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Pet Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Pet Vaccine Market Share Forecast by Type (2021-2025)
12.4 Pet Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Pet Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Pet Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Pet Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Pet Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Pet Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Bayer Healthcare Basic Information, Manufacturing Base and Competitors
Table 8. Bayer Healthcare Pet Vaccine Major Business
Table 9. Bayer Healthcare Pet Vaccine Total Revenue (USD Million) (2018-2019)
Table 10. Bayer Healthcare SWOT Analysis
Table 11. Bayer Healthcare Pet Vaccine Product and Services
Table 12. Bayer Healthcare Pet Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Merial (Sanofi) Basic Information, Manufacturing Base and Competitors
Table 14. Merial (Sanofi) Pet Vaccine Major Business
Table 15. Merial (Sanofi) Pet Vaccine Total Revenue (USD Million) (2018-2019)
Table 16. Merial (Sanofi) SWOT Analysis
Table 17. Merial (Sanofi) Pet Vaccine Product and Services
Table 18. Merial (Sanofi) Pet Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Ceva Basic Information, Manufacturing Base and Competitors
Table 20. Ceva Pet Vaccine Major Business
Table 21. Ceva Pet Vaccine Total Revenue (USD Million) (2018-2019)
Table 22. Ceva SWOT Analysis
Table 23. Ceva Pet Vaccine Product and Services
Table 24. Ceva Pet Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Vetoquinol S.A Basic Information, Manufacturing Base and Competitors
Table 26. Vetoquinol S.A Pet Vaccine Major Business
Table 27. Vetoquinol S.A Pet Vaccine Total Revenue (USD Million) (2018-2019)
Table 28. Vetoquinol S.A SWOT Analysis
Table 29. Vetoquinol S.A Pet Vaccine Product and Services
Table 30. Vetoquinol S.A Pet Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 32. Merck Animal Health Pet Vaccine Major Business
Table 33. Merck Animal Health Pet Vaccine Total Revenue (USD Million) (2018-2019)
Table 34. Merck Animal Health SWOT Analysis
Table 35. Merck Animal Health Pet Vaccine Product and Services
Table 36. Merck Animal Health Pet Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 38. Boehringer Ingelheim Pet Vaccine Major Business
Table 39. Boehringer Ingelheim Pet Vaccine Total Revenue (USD Million) (2018-2019)
Table 40. Boehringer Ingelheim SWOT Analysis
Table 41. Boehringer Ingelheim Pet Vaccine Product and Services
Table 42. Boehringer Ingelheim Pet Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Zoetis (Pfizer) Basic Information, Manufacturing Base and Competitors
Table 44. Zoetis (Pfizer) Pet Vaccine Major Business
Table 45. Zoetis (Pfizer) Pet Vaccine Total Revenue (USD Million) (2018-2019)
Table 46. Zoetis (Pfizer) SWOT Analysis
Table 47. Zoetis (Pfizer) Pet Vaccine Product and Services
Table 48. Zoetis (Pfizer) Pet Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Heska Co. Basic Information, Manufacturing Base and Competitors
Table 50. Heska Co. Pet Vaccine Major Business
Table 51. Heska Co. Pet Vaccine Total Revenue (USD Million) (2018-2019)
Table 52. Heska Co. SWOT Analysis
Table 53. Heska Co. Pet Vaccine Product and Services
Table 54. Heska Co. Pet Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 56. Eli Lilly Pet Vaccine Major Business
Table 57. Eli Lilly Pet Vaccine Total Revenue (USD Million) (2018-2019)
Table 58. Eli Lilly SWOT Analysis
Table 59. Eli Lilly Pet Vaccine Product and Services
Table 60. Eli Lilly Pet Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Virbac Basic Information, Manufacturing Base and Competitors
Table 62. Virbac Pet Vaccine Major Business
Table 63. Virbac Pet Vaccine Total Revenue (USD Million) (2018-2019)
Table 64. Virbac SWOT Analysis
Table 65. Virbac Pet Vaccine Product and Services
Table 66. Virbac Pet Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Pet Vaccine Sales by Manufacturer (2018-2019) (K Doses)
Table 68. Global Pet Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Pet Vaccine Sales by Regions (2015-2020) (K Doses)
Table 70. Global Pet Vaccine Sales Market Share by Regions (2015-2020)
Table 71. Global Pet Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Pet Vaccine Sales by Countries (2015-2020) (K Doses)
Table 73. North America Pet Vaccine Sales Market Share by Countries (2015-2020)
Table 74. North America Pet Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Pet Vaccine Revenue Market Share by Countries (2015-2020)
Table 76. Europe Pet Vaccine Sales by Countries (2015-2020) (K Doses)
Table 77. Europe Pet Vaccine Sales Market Share by Countries (2015-2020)
Table 78. Europe Pet Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Pet Vaccine Sales by Regions (2015-2020) (K Doses)
Table 80. Asia-Pacific Pet Vaccine Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Pet Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Pet Vaccine Sales by Countries (2015-2020) (K Doses)
Table 83. South America Pet Vaccine Sales Market Share by Countries (2015-2020)
Table 84. South America Pet Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Pet Vaccine Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Pet Vaccine Sales by Countries (2015-2020) (K Doses)
Table 87. Middle East & Africa Pet Vaccine Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Pet Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Pet Vaccine Revenue Market Share by Countries (2015-2020)
Table 90. Global Pet Vaccine Sales by Type (2015-2020) (K Doses)
Table 91. Global Pet Vaccine Sales Share by Type (2015-2020)
Table 92. Global Pet Vaccine Revenue by Type (2015-2020) (USD Million)
Table 93. Global Pet Vaccine Revenue Share by Type (2015-2020)
Table 94. Global Pet Vaccine Sales by Application (2015-2020) (K Doses)
Table 95. Global Pet Vaccine Sales Share by Application (2015-2020)
Table 96. Global Pet Vaccine Sales Forecast by Regions (2021-2025) (K Doses)
Table 97. Global Pet Vaccine Market Share Forecast by Regions (2021-2025)
Table 98. Global Pet Vaccine Sales Forecast by Type (2021-2025) (K Doses)
Table 99. Global Pet Vaccine Market Share Forecast by Type (2021-2025)
Table 100. Global Pet Vaccine Sales Forecast by Application (2021-2025)
Table 101. Global Pet Vaccine Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Pet Vaccine Picture
Figure 2. Global Sales Market Share of Pet Vaccine by Type in 2019
Figure 3. Attenuated Live Vaccines Picture
Figure 4. Conjugate Vaccines Picture
Figure 5. Inactivated Vaccines Picture
Figure 6. Subunit Vaccines Picture
Figure 7. Toxoid Vaccines Picture
Figure 8. DNA Vaccines Picture
Figure 9. Recombinant Vaccines Picture
Figure 10. Pet Vaccine Sales Market Share by Application in 2018
Figure 11. Canine Picture
Figure 12. Avian Picture
Figure 13. Feline Picture
Figure 14. Global Pet Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 15. United States Pet Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Canada Pet Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Mexico Pet Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Germany Pet Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. France Pet Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. UK Pet Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Russia Pet Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Italy Pet Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. China Pet Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Japan Pet Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Korea Pet Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. India Pet Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Southeast Asia Pet Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Australia Pet Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 29. Brazil Pet Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Egypt Pet Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Saudi Arabia Pet Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 32. South Africa Pet Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Turkey Pet Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Global Pet Vaccine Sales Market Share by Manufacturer in 2019
Figure 35. Global Pet Vaccine Revenue Market Share by Manufacturer in 2019
Figure 36. Top 3 Pet Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 37. Top 6 Pet Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 38. Key Manufacturer Market Share Trend
Figure 39. Global Pet Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 40. Global Pet Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 41. Global Pet Vaccine Revenue Market Share by Regions (2015-2020)
Figure 42. Global Pet Vaccine Revenue Market Share by Regions in 2018
Figure 43. North America Pet Vaccine Sales and Growth Rate (2015-2020)
Figure 44. Europe Pet Vaccine Sales and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Pet Vaccine Sales and Growth Rate (2015-2020)
Figure 46. South America Pet Vaccine Sales and Growth Rate (2015-2020)
Figure 47. Middle East & Africa Pet Vaccine Sales and Growth Rate (2015-2020)
Figure 48. North America Pet Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 49. North America Pet Vaccine Sales Market Share by Countries (2015-2020)
Figure 50. North America Pet Vaccine Sales Market Share by Countries in 2018
Figure 51. North America Pet Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 52. North America Pet Vaccine Revenue Market Share by Countries in 2018
Figure 53. United States Pet Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 54. Canada Pet Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 55. Mexico Pet Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 56. Europe Pet Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 57. Europe Pet Vaccine Revenue Market Share by Countries (2015-2020)
Figure 58. Europe Pet Vaccine Revenue Market Share by Countries in 2019
Figure 59. Germany Pet Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 60. UK Pet Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 61. France Pet Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 62. Russia Pet Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 63. Italy Pet Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 64. Asia-Pacific Pet Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 65. Asia-Pacific Pet Vaccine Sales Market Share by Regions 2019
Figure 66. Asia-Pacific Pet Vaccine Revenue Market Share by Regions 2019
Figure 67. China Pet Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 68. Japan Pet Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 69. Korea Pet Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 70. India Pet Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 71. Southeast Asia Pet Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 72. South America Pet Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. South America Pet Vaccine Sales Market Share by Countries in 2019
Figure 74. South America Pet Vaccine Revenue Market Share by Countries in 2019
Figure 75. Brazil Pet Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 76. Argentina Pet Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 77. Middle East and Africa Pet Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. Middle East and Africa Pet Vaccine Sales Market Share by Countries in 2019
Figure 79. Middle East and Africa Pet Vaccine Revenue Market Share by Countries (2015-2020)
Figure 80. Middle East and Africa Pet Vaccine Revenue Market Share by Countries in 2019
Figure 81. Saudi Arabia Pet Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 82. Egypt Pet Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 83. Turkey Pet Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 84. South Africa Pet Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 85. Global Pet Vaccine Sales and Growth Rate (2021-2025) (K Doses)
Figure 86. Global Pet Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 87. North America Sales Pet Vaccine Market Forecast (2021-2025) (K Doses)
Figure 88. Europe Sales Pet Vaccine Market Forecast (2021-2025) (K Doses)
Figure 89. Asia-Pacific Sales Pet Vaccine Market Forecast (2021-2025) (K Doses)
Figure 90. South America Sales Pet Vaccine Market Forecast (2021-2025) (K Doses)
Figure 91. Middle East & Africa Sales Pet Vaccine Market Forecast (2021-2025) (K Doses)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel
治療用ワクチンの世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The global Therapeutic Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Therapeutic Vaccines mar…- 旅行者用ワクチンの世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The Travelers Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- デング熱ワクチンの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Dengue Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Dengue Vaccines market report…
- mRNAワクチン及び治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The mRNA Vaccines & Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- mRNAワクチン及び治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The mRNA Vaccines & Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…